Retractable Technologies (RVP) 2.70 $RVP Retractable

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Retractable Technologies (RVP) 2.70 $RVP

Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock Shareholders
BusinessWire - Thu Sep 22, 12:46PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,312.50 and $42,800.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from and including July 1, 2016 through date of conversion or September 30, 2016, whichever is applicable. The dividends will be paid on October 20, 2016 to shareholders of record as of the close of business on October 10, 2016.
RVP: 2.70 (+0.12)

Retractable Technologies, Inc. Reports Results as of June 30, 2016
BusinessWire - Tue Aug 16, 2:21PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and six months ended June 30, 2016 and 2015, respectively.
RVP: 2.70 (+0.12)

Retractable Technologies, Inc. Reports Results for the First Quarter of 2016
BusinessWire - Tue May 17, 12:19PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) reported the following results of operations for the first quarter of 2016 and other matters in its quarterly report on Form 10-Q filed on May 16, 2016.
RVP: 2.70 (+0.12)

Oral Argument Calendared for Retractable Technologies, Inc.
BusinessWire - Thu Jan 28, 11:36AM CST
Retractable Technologies, Inc. (NYSE MKT: RVP) reports that oral argument before the United States Court of Appeals for the Fifth Circuit has been set on the Court's calendar for Monday, February 29, 2016 in New Orleans, LA.
RVP: 2.70 (+0.12)

BUYINS.NET: RVP SqueezeTrigger Price is $2.75. There is $44,597 That Short Sellers Still Need To Cover.
M2 - Fri Jan 15, 3:10AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring Retractable Technologies Inc (NYSE:RVP) in real time and just received an alert that RVP is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 16100 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $2.75. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
RVP: 2.70 (+0.12)

BUYINS.NET: RVP SqueezeTrigger Price is $2.75. There is $46,953 That Short Sellers Still Need To Cover.
M2 - Fri Dec 04, 11:34AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring Retractable Technologies Inc (NYSE:RVP) in real time and just received an alert that RVP is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 13500 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $2.75. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
RVP: 2.70 (+0.12)

Evaluating the Technicals - Research on Hudson Technologies, Retractable Technologies, Spark Networks and MediciNova
ACCESSWIRE - Wed Dec 02, 6:45AM CST
NEW YORK, NY / ACCESSWIRE / December 02, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hudson Technologies Inc. (NASDAQ: HDSN), Retractable Technologies Inc. (NYSE MKT: RVP), Spark Networks Inc. (NYSE MKT: LOV) and MediciNova Inc. (NASDAQ: MNOV). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
HDSN: 6.39 (+0.01), MNOV: 7.10 (+0.03), RVP: 2.70 (+0.12), LOV: 1.69 (+0.01)

Retractable Technologies, Inc. Reports Results for the Third Quarter of 2015
BusinessWire - Tue Nov 17, 7:00AM CST
Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and nine months ended September 30, 2015 and 2014, respectively.
RVP: 2.70 (+0.12)

Retractable Technologies to pay dividends on preferred stock
M2 - Mon Sep 28, 6:20AM CDT
The board of directors of Retractable Technologies (NYSE MKT:RVP) on Friday declared a dividend of USD0.125 per share on the company's Series I Class B convertible preferred stock as well as USD0.25 per share on its Series II Class convertible preferred stock.
RVP: 2.70 (+0.12)

Disposable Syringes Market (Safety and Conventional Syringes): Global Industry Analysis 2014 - 2022
M2 - Wed Jul 01, 9:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jlbkkq/disposable) has announced the addition of the "Disposable Syringes Market (safety and conventional syringes): Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022" report to their offering. The global disposable syringes market was valued at USD 4,935.7 million in 2013 and is projected to reach USD 7,552.5 million by 2022, expanding at a CAGR of 4.9% during the forecast period from 2014 to 2022. Growth in the injectable drugs market along with increasing needlestick injuries has boosted demand for safe disposable syringes across the world. Disposable syringes have been identified as one of the fastest growing segments of the syringe market, accounting for approximately 70% to 80% of the global market in 2013. Globally, disposable syringes are becoming more popular than re-usable syringes, primarily due to cost, accuracy, sterility, and ease of handling. Increasing cases of needlestick injuries, strict regulatory guidelines, and overall growth in the injectable drugs market have been identified as the major factors driving the growth of the global disposable syringes market. The disposable syringes market has been segmented into two major types: safety syringes and conventional syringes. Syringes equipped with safety mechanisms are known as safety syringes. Safety syringes have been further categorized into automatic retractable safety syringes, manual retractable safety syringes, and non-retractable safety syringes. Conventional syringes are not equipped with any kind of safety mechanisms. Conventional syringes have been classified into syringes without needles and syringes attached with needles. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Disposable Syringes Market Overview Chapter 4 Global Disposable Syringes Market Revenue (USD Million) and Volume (Million Units), by Type, 2012 - 2022 Chapter 5 Global Disposable Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2012 - 2022 Chapter 6 Recommendations Chapter 7 Company Profiles - B. Braun Melsungen AG - Becton, Dickinson & Company - CODAN Medizinische Ger?te GmbH & Co KG - Covidien plc (Medtronic plc) - Gerresheimer AG - Retractable Technologies, Inc. - Smiths Medical - Star Syringe Ltd. - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/jlbkkq/disposable
BDX: 179.50 (-2.05), UNIS: 2.65 (-0.13), MDT: 87.71 (-0.11), RVP: 2.70 (+0.12)

Retractable Technologies' board to pay dividends on preferred stock
M2 - Mon Jun 29, 5:00AM CDT
The board of directors of Retractable Technologies (NYSE MKT:RVP), a safety medical products company, declared on Friday dividends of USD12,312.50 and USD44,050.00 to holders of its Series I Class B and Series II Class B convertible preferred stock, respectively.
RVP: 2.70 (+0.12)

Retractable Technologies reports recognition of USD7.72m payment in Q2 2015
M2 - Fri May 22, 6:01AM CDT
Safety medical products company Retractable Technologies (NYSE MKT:RVP) said on Thursday that it will record USD7.72m as income in the Q2 2015.
RVP: 2.70 (+0.12)

Retractable Technologies, Inc. Reports Recognition of Payment
BusinessWire - Thu May 21, 2:44PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) ("RTI" reports that in the second quarter of 2015, RTI will record as income and remove from RTI's current liabilities, the $7,724,826 judgment amount previously paid by Becton, Dickinson and Company ("BD" for damages awarded as a result of BD's infringement of RTI's patents. This patent infringement case and related appeals have concluded.
RVP: 2.70 (+0.12)

Retractable Technologies, Inc. Reports Improved Results for the First Quarter 2015
BusinessWire - Fri May 15, 11:38AM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three months ended March 31, 2015 and 2014, respectively.
RVP: 2.70 (+0.12)

Retractable Technologies, Inc. Announces Amended Final Judgment and Notice of Appeal
BusinessWire - Mon Apr 27, 1:07PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) ("RTI" announced that on April 23, 2015, the United States District Court for the Eastern District of Texas, Marshall Division, entered an Amended Final Judgment in RTI's suit against Becton, Dickinson and Company ("BD" for antitrust and other claims.
RVP: 2.70 (+0.12)

Retractable Technologies, Inc. Announces U.S. Supreme Court Decision - Denial of Writ of Certiorari
BusinessWire - Tue Apr 21, 10:18AM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) announced that on April 20, 2015, the Supreme Court of the United States denied the petition for a writ of certiorari by Becton, Dickinson and Company ("BD" relating to its Rule 60(b) motion in the portion of Retractable's case against BD addressing patent infringement claims.
RVP: 2.70 (+0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 276

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 238

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 522

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 271

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 202

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 104

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Canadian Stocks Surge: Understanding Market Dynamics and Trends

Updated Category News Views 178

Canadian Stocks See Notable Gains The Canadian stock market has shown encouraging signs of growth lately, with various sectors playing a part in this upward movement. The S&P/TSX Composite Index achieved a remarkable increase of 0.57%, marking a significant point in its trading history. Key Sectors Driving Market Growth The rise in stock prices can largely be credited to...

Continue Reading
Bookmark Medical Enters Michigan Via Village Medical Buy

Updated Category News Views 38

Stepping into Michigan It might not be a Wall Street headliner, but Bookmark Medical's move into Michigan sure says a lot about their growth ambitions. On August 3, 2026, the Nashville-based healthcare group wrapped up acquiring Village Medical Michigan. This is Bookmark's maiden voyage into the Great Lake State, where it's taken over the reins of seven primary care...

Continue Reading
Astrotech Corporation Reports Impressive Year-End Results

Updated Category News Views 134

Astrotech Corporation Reports Strong Fiscal Performance Recently, Astrotech Corporation (NASDAQ: ASTC) announced its financial results for the fiscal year that ended on June 30. The report highlights notable advancements from its subsidiary, 1st Detect, and how these developments are contributing to overall revenue and growth potential. Key Financial Highlights The...

Continue Reading
Neptune Flood Research Highlights Path to Private Insurance Transition

Updated Category News Views 165

Neptune Flood Research Report Offers Insights on NFIP Transition Recent research indicates that private flood insurers may be capable of taking on 95% of policies from the NFIP, helping to mitigate federal financial exposure. Neptune Flood Research Group has published a comprehensive report analyzing the U.S. flood insurance market. The study emphasizes the challenges...

Continue Reading
Valerio Therapeutics Shifts Focus to Early-Stage Drug Development

Updated Category News Views 131

Valerio Therapeutics Announces Strategic Refocus Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) has made a pivotal announcement regarding its strategic business direction. The company has decided to halt all clinical trials, including the ongoing VIO-01 trial. This decision comes in response to significant financing challenges impacting the organization. While...

Continue Reading